Cite
APA Citation
Gross-Goupil, M., Kwon, T. G., Eto, M., Ye, D., Miyake, H., Seo, S. I., Byun, S. -., Lee, J. L., Master, V., Jin, J., DeBenedetto, R., Linke, R., Casey, M., Rosbrook, B., Lechuga, M., Valota, O., Grande, E., & Quinn, D. I. (2018). axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial. Annals of oncology, 29, 2371–2378. http://access.bl.uk/ark:/81055/vdc_100095487005.0x00003a